Reference priceKRW ₩258,187.50Original source price: INR 15,937.50. Converted estimates are available by currency selection.
| Brand | INTAS PHARMACEUTICALS LTD |
|---|---|
| Manufacturer | Intas Pharmaceuticals Ltd. |
| Prescription required | Yes |
Razumab 2.3mg Injection
Ranibizumab (2.3mg)
Description
Razumab 2.3mg injection, contains the active ingredient Ranibizumab. It is an anti-neovascularisation agent in the class of medications called vascular endothelial growth factor A (VEGF-A) antagonists. It is used in adults to treat several eye diseases causing vision impairment. It is used to treat wet age-related macular degeneration (AMD, a persistent eye disease that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities).Benefits
Uses of Razumab Injection 1.Diabetic eye disease 2.Wet age-related macular degeneration 3.Macular edema due to retinal vein occlusionHow to Use
Your doctor or nurse will give you this medicine. Kindly do not self administer.Specification
Your doctor or nurse will give you this medicine. Kindly do not self administer.Side Effects
Side effects of Razumab Injection Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Razumab Conjunctival hemorrhage Eye pain Increased intraocular pressure Foreign body sensation in eyes Blurred vision Nausea Dry eye Eye itching Cataract Vitreous floaters Vitreous detachment Intraocular inflammation Eye irritation Increased lacrimation Eyelid inflammation이 정보는 참고용입니다. 의약품 사용 전 의료 전문가와 상담하세요.